Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03338972 · COMPLETED
Trial details
- NCT number
- NCT03338972
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2021-05-03
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.